News
Dr. Peter Marks, the former director of the FDA’s Center for Biologics Evaluation and Research, urged public health leaders ...
A recipient of the 2025 Elite Trial Lawyers Lifetime Achievement Award, Morgan & Morgan's John Yanchunis spoke with the National Law Journal about his storied career, from bringing one of the nation’s ...
Trump administration officials have defended the mass dismissals, saying they are overdue and necessary to make the ...
Trump celebrated when the Supreme Court limited nationwide blocks on his policies, but judges are finding other ways to ...
18h
Clinical Trials Arena on MSNSarepta refuses to pull gene therapy despite FDA requestSarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.
The U.S. Congressional Budget Office (CBO) cautioned that President Trumps proposed 2026 federal budgetfeaturing deep cuts to ...
The Food and Drug Administration is developing a plan to shift more food safety inspections over to state partners over the ...
Sarepta Therapeutics’ stock has dropped precipitously as questions swirl around the safety of its gene therapies. Meanwhile, the Duchenne patient community fears losing access to Elevidys while the ...
4don MSN
Six employees died after catastrophic flooding from Helene. DA Steven Finney said no charges will be filed after the TBI ...
Markets only work when transparent prices reflect consumers' desires and the producers' costs. While there are complications, ...
Shortly after Mr. Blanche posted his invitation, the House Oversight Committee voted to subpoena Ms. Maxwell. The motion was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results